Hester Biosciences Limited has informed the Exchange about Schedule of meet
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has scheduled an investor conference call for Wednesday, 12 November 2025 at 2:00 p.m. IST, following the announcement of its financial results for the quarter and six months ended 30 September 2025 (Q2FY26 and H1FY26). The call will be led by CEO & Managing Director Mr. Rajiv Gandhi, Executive Director Ms. Priya Gandhi, and CFO Mr. Divyesh Maru. ICICI Securities is coordinating the call, with a Diamond Pass registration link provided for investors to join. The intimation has been filed with both BSE and NSE under SEBI Listing Regulations.
This is a routine regulatory disclosure ahead of the upcoming Q2FY26 earnings announcement. Investors and analysts should watch for the financial results expected around the same time, as the conference call will provide management commentary and guidance on the company's performance for the quarter and half-year.